Member Info for Babbler2

Comms via RNS Reach has increased.
Not issue RNSs to echo past releases. IE normal course of business... don't want to mislead investors regarding value.

email updates available.

Directors take less salary than the mean industry average.

NAV was £1.7m when ceo took charge now £16.8m

DA nav was less than £1m now £11,7m

questions

directors shareholding... up to individuals to decide cant be enforced

Shareprice decline by 80% - important for PIs to recognise generally valued on NAV and NAV/Share value

NAV is £17m NAV per share 7.1p as of dec.

Range of factors outside control of tern.

Ability to create value is attractive to US venture capital.

Come a long way in 3 years to create more systemized deal flow.

Create shareholder value

Not bad for £500k investment...

Far shorter sales cycles and greater impact on conversation with customers. Bring more revenue to the table... lessons learned.

HID partnership is significant sales and resale partnership

DA had 9 US patents. Seminal in this area. Capabilities can not be replicated.

Fundamental - lots of lessons learned. How to accelerate

DA at stage 3 and book value of £11m

$10m per annum... not too shabby for this tiddler... just from AU... with USA and Europe too... well you know.

perhaps wee need to find some oil and get a sheikh to invest...

maybe give it time? Only 18% available in freefloat... doesn't help that people buy and sell 30mins later for a loss when freefloat so low.

oh its ben noticed ;) 15% freefloat is nothing...

Another excellent RNS... this is far too under the radar imo and with only around 15% in public hands...

" providing an estimated total market opportunity for Alkindi® and Chronocort® of approximately $10 million per annum (USD). "

$10m a year market opportunity in AU alone for Chronocort alone... one to tuck away... with US and Europe launches too... imo.

good find imo.!

offer last week was 6p... your point being...?

"Wipro and DA are delivering a joint solution for a LARGE MULTINATIONAL healthcare company which is launching a remote patient monitoring service"

DELIVERING not MAY BE DELIVERING... and yeah they are doing it for free right? jeez...

As you are so concerned maybe ask that question before the call to be answered tomorrow... imo.

wasn't the last placing at 8.5p ? Surprised selling below tbh... as for "get shot of placing shares..." good! That's whats holding this back... another 500 gone... the remaining 1.5m will be done today / tomorrow then - preferably before investor call.

Its still only just at the price from October... allowing for dilution.... it fell from a lot higher remember...

looks like most their news comes out like todays news. Doesn't mean no value to it!

once the placing churn is done (almost there,,,) then 13p short term (1 month max) target. So long I know... lmao